ATE464901T1 - Verwendung von pipamperon und einem d2-rezeptor antagonisten oder einem serotonin/dopamin antagonisten zur behandlung von psychotischen störungen - Google Patents

Verwendung von pipamperon und einem d2-rezeptor antagonisten oder einem serotonin/dopamin antagonisten zur behandlung von psychotischen störungen

Info

Publication number
ATE464901T1
ATE464901T1 AT04801138T AT04801138T ATE464901T1 AT E464901 T1 ATE464901 T1 AT E464901T1 AT 04801138 T AT04801138 T AT 04801138T AT 04801138 T AT04801138 T AT 04801138T AT E464901 T1 ATE464901 T1 AT E464901T1
Authority
AT
Austria
Prior art keywords
antagonist
pipamperone
serotonin
treatment
psychotic disorders
Prior art date
Application number
AT04801138T
Other languages
German (de)
English (en)
Inventor
Erik Buntinx
Original Assignee
Pharmaneuroboost N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03447279A external-priority patent/EP1547650A1/en
Priority claimed from US10/725,965 external-priority patent/US7884096B2/en
Priority claimed from CA2451798A external-priority patent/CA2451798C/en
Priority claimed from US10/752,423 external-priority patent/US7855195B2/en
Priority claimed from EP04447066A external-priority patent/EP1576985A1/en
Priority claimed from CA 2461248 external-priority patent/CA2461248C/en
Priority claimed from US10/803,793 external-priority patent/US20050119249A1/en
Priority claimed from EP04025035A external-priority patent/EP1541197B8/en
Priority claimed from US10/984,683 external-priority patent/US20050203130A1/en
Priority claimed from CA 2487529 external-priority patent/CA2487529A1/en
Application filed by Pharmaneuroboost N V filed Critical Pharmaneuroboost N V
Priority claimed from PCT/BE2004/000172 external-priority patent/WO2005053796A1/en
Publication of ATE464901T1 publication Critical patent/ATE464901T1/de
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04801138T 2003-12-02 2004-12-02 Verwendung von pipamperon und einem d2-rezeptor antagonisten oder einem serotonin/dopamin antagonisten zur behandlung von psychotischen störungen ATE464901T1 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
EP03447279A EP1547650A1 (en) 2003-12-02 2003-12-02 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA2451798A CA2451798C (en) 2003-12-02 2003-12-02 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
US10/725,965 US7884096B2 (en) 2003-12-02 2003-12-02 Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP04447001 2004-01-05
US10/752,423 US7855195B2 (en) 2003-12-02 2004-01-06 Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP04447066A EP1576985A1 (en) 2004-03-18 2004-03-18 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA 2461248 CA2461248C (en) 2003-12-02 2004-03-18 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
US10/803,793 US20050119249A1 (en) 2003-12-02 2004-03-18 Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP04025035A EP1541197B8 (en) 2003-12-02 2004-10-21 Use of pipamperone and an SNDRI, SNRI or SSRI for the treatment of mood or anxiety disorders
JP2004349085A JP4571485B2 (ja) 2003-12-02 2004-11-04 Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用
US10/984,683 US20050203130A1 (en) 2003-12-02 2004-11-09 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA 2487529 CA2487529A1 (en) 2003-12-02 2004-11-15 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
PCT/BE2004/000172 WO2005053796A1 (en) 2003-12-02 2004-12-02 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists

Publications (1)

Publication Number Publication Date
ATE464901T1 true ATE464901T1 (de) 2010-05-15

Family

ID=42134278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04801138T ATE464901T1 (de) 2003-12-02 2004-12-02 Verwendung von pipamperon und einem d2-rezeptor antagonisten oder einem serotonin/dopamin antagonisten zur behandlung von psychotischen störungen

Country Status (8)

Country Link
AT (1) ATE464901T1 (sl)
DE (1) DE602004026781D1 (sl)
DK (1) DK1708790T3 (sl)
ES (1) ES2343962T3 (sl)
HR (1) HRP20100376T1 (sl)
PT (1) PT1708790E (sl)
RS (1) RS51331B (sl)
SI (1) SI1708790T1 (sl)

Also Published As

Publication number Publication date
ES2343962T3 (es) 2010-08-13
DK1708790T3 (da) 2010-06-21
SI1708790T1 (sl) 2010-09-30
DE602004026781D1 (de) 2010-06-02
RS51331B (en) 2011-02-28
PT1708790E (pt) 2010-07-09
HRP20100376T1 (hr) 2010-08-31

Similar Documents

Publication Publication Date Title
DE60319865D1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
DE60204548D1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
ZA200509542B (en) Combination of an NDMA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
DE60332269D1 (de) Vorrichtung zur gerichteten stimulation von nerven
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
ATE545637T1 (de) Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen
DE60329015D1 (de) Verfahren zur hemmung der acrylamidbildungund seine verwendung
ATE494279T1 (de) Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate
DE60310592D1 (de) Geneigte schraubenfedern verschiedener ausführung
DE602005020209D1 (de) System zur Evaluierung von Herzstörungen
IL187248A0 (en) Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
ATE529156T1 (de) System und verfahren zum umgang mit atemstörungen
ATE374030T1 (de) Kombination eines mglur2 antagonists und eines ache inhibitors zur behandlung von akuten und/oder chronischen neurologischen krankheiten
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens
ATE303379T1 (de) 4-(phenyl-piperidin-4-ylidenmethyl)-benzamid- derivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602004002231D1 (de) Knochenkontaktierendes Implantat mit stossdämpfenden Eigenschaften und Verfahren zu dessen Herstellung
ATE503752T1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
DE602006010737D1 (de) 3-(4-äÄ4-(4äÄ3-(3,3-DIMETHYL-1-PIPERIDINYL)PROPYLÄOXYÜPHINYLÜ-1-PIPERIDINYLCARBONYLü-1-NAPHTHALINYL)PROPAN- ODER PROPENSÄURE ALS H1- UND H3-REZEPTOR-ANTAGONISTEN ZUR BEHANDLUNG ENTZÜNDLICHER UND/ODER ALLERGISCHER ERKRANKUNGEN
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
IL176453A0 (en) Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
ATE362923T1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
DE60305400D1 (de) Anlage zur Behandlung von Produkten und dazugehörige Datenerfassungseinheit
ATE393766T1 (de) Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708790

Country of ref document: EP